BioSpace News Archive

Inspire Medical Systems, Inc. announced today that its management team will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at the Westin St. Francis Hotel in San Francisco, CA.

Agios Pharmaceuticals, Inc. today announced that the company is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 7:30 a.m. PT.

Aerami Therapeutics Holdings, Inc today announced the appointment of Lisa Yañez as chief executive officer, effective January 1, 2023.

Aerami Therapeutics Holdings, Inc (“Aerami”), a clinical stage biopharmaceutical company dedicated to breathing life into the treatment of serious cardiopulmonary and cardiometabolic conditions, today announced completion of dosing in a Phase 1 study of AER-901, a drug-device combination comprised of imatinib for inhalation and the FOX® nebulizer.

Motus GI Holdings, Inc. today provided an update on the development of its Pure-Vu® EVS system compatible with gastroscopes used during upper gastrointestinal (GI) endoscopy procedures to remove blood, blood clots and debris in order to provide a clear field-of-view for the endoscopist.

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced it has achieved the target enrollment of approximately 3,000 participants in the groundbreaking Phase 2 PENINSULA trial evaluating VIR-2482 for the prevention of illness due to influenza A.

Akadeum Life Sciences, Inc. , a global leader in buoyancy-based cell separation technology, announces their Microbubble Leukopak Human T Cell Isolation research-use-only kit that resulted from successful external user data with early adopters.

Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (“Therma” or the “Company”), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to provide a summary of activities and accomplishments achieved during 2022 as outlined below.

The global plasma derived therapy market size was exhibited at USD 19.54 billion in 2022 and it is expected to hold around USD 33.75 billion by 2030, growing at a CAGR of 7.07% from 2022 to 2030.

Tryp Therapeutics, Inc. (CSE: TRYP) (OTCQB: TRYPF) today announced that the Company will be presenting at the Biotech Showcase on Monday, January 9, 2023, at the Hilton San Francisco Union Square Hotel in San Francisco, CA.